Logo image of VRA

VERA BRADLEY INC (VRA) Stock Fundamental Analysis

USA - Nasdaq - NASDAQ:VRA - US92335C1062 - Common Stock

2.82 USD
-0.02 (-0.7%)
Last: 1/16/2026, 9:54:44 AM
Fundamental Rating

2

VRA gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 45 industry peers in the Textiles, Apparel & Luxury Goods industry. The financial health of VRA is average, but there are quite some concerns on its profitability. VRA does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

1

1. Profitability

1.1 Basic Checks

  • VRA had negative earnings in the past year.
  • VRA had a negative operating cash flow in the past year.
  • The reported net income has been mixed in the past 5 years: VRA reported negative net income in multiple years.
  • In multiple years VRA reported negative operating cash flow during the last 5 years.
VRA Yearly Net Income VS EBIT VS OCF VS FCFVRA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20M -20M 40M -40M 60M -60M

1.2 Ratios

  • VRA has a Return On Assets of -40.00%. This is amonst the worse of the industry: VRA underperforms 91.11% of its industry peers.
  • With a Return On Equity value of -76.11%, VRA is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
Industry RankSector Rank
ROA -40%
ROE -76.11%
ROIC N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
VRA Yearly ROA, ROE, ROICVRA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 10 -10 -20 -30

1.3 Margins

  • With a Gross Margin value of 45.45%, VRA is not doing good in the industry: 60.00% of the companies in the same industry are doing better.
  • In the last couple of years the Gross Margin of VRA has declined.
  • The Profit Margin and Operating Margin are not available for VRA so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 45.45%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
VRA Yearly Profit, Operating, Gross MarginsVRA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 20 40

4

2. Health

2.1 Basic Checks

  • VRA does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • The number of shares outstanding for VRA has been reduced compared to 1 year ago.
  • VRA has less shares outstanding than it did 5 years ago.
  • There is no outstanding debt for VRA. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
VRA Yearly Shares OutstandingVRA Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 10M 20M 30M
VRA Yearly Total Debt VS Total AssetsVRA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 100M 200M 300M 400M 500M

2.2 Solvency

  • VRA has an Altman-Z score of 2.24. This is not the best score and indicates that VRA is in the grey zone with still only limited risk for bankruptcy at the moment.
  • Looking at the Altman-Z score, with a value of 2.24, VRA is doing worse than 60.00% of the companies in the same industry.
  • VRA has a Debt/Equity ratio of 0.08. This is a healthy value indicating a solid balance between debt and equity.
  • The Debt to Equity ratio of VRA (0.08) is better than 82.22% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Altman-Z 2.24
ROIC/WACCN/A
WACC11.36%
VRA Yearly LT Debt VS Equity VS FCFVRA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0 100M 200M 300M

2.3 Liquidity

  • VRA has a Current Ratio of 2.52. This indicates that VRA is financially healthy and has no problem in meeting its short term obligations.
  • VRA has a Current ratio of 2.52. This is in the better half of the industry: VRA outperforms 71.11% of its industry peers.
  • VRA has a Quick Ratio of 2.52. This is a bad value and indicates that VRA is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.81, VRA is not doing good in the industry: 73.33% of the companies in the same industry are doing better.
Industry RankSector Rank
Current Ratio 2.52
Quick Ratio 0.81
VRA Yearly Current Assets VS Current LiabilitesVRA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 50M 100M 150M 200M 250M

1

3. Growth

3.1 Past

  • VRA shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -308.33%.
  • Looking at the last year, VRA shows a very negative growth in Revenue. The Revenue has decreased by -29.74% in the last year.
  • Measured over the past years, VRA shows a decrease in Revenue. The Revenue has been decreasing by -5.56% on average per year.
EPS 1Y (TTM)-308.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
Revenue 1Y (TTM)-29.74%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-22.74%

3.2 Future

  • Based on estimates for the next years, VRA will show a very strong growth in Earnings Per Share. The EPS will grow by 44.14% on average per year.
  • The Revenue is expected to decrease by -15.90% on average over the next years. This is quite bad
EPS Next Y-4.11%
EPS Next 2Y44.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-30.39%
Revenue Next 2Y-15.9%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
VRA Yearly Revenue VS EstimatesVRA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
VRA Yearly EPS VS EstimatesVRA Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 1

1

4. Valuation

4.1 Price/Earnings Ratio

  • The Price/Earnings Ratio is negative for VRA. In the last year negative earnings were reported.
  • A Price/Forward Earnings ratio of 55.84 indicates a quite expensive valuation of VRA.
  • 73.33% of the companies in the same industry are cheaper than VRA, based on the Price/Forward Earnings ratio.
  • When comparing the Price/Forward Earnings ratio of VRA to the average of the S&P500 Index (24.31), we can say VRA is valued expensively.
Industry RankSector Rank
PE N/A
Fwd PE 55.84
VRA Price Earnings VS Forward Price EarningsVRA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 10 20 30 40 50

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
VRA Per share dataVRA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6 8 10

4.3 Compensation for Growth

  • A more expensive valuation may be justified as VRA's earnings are expected to grow with 44.14% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y44.14%
EPS Next 3YN/A

0

5. Dividend

5.1 Amount

  • No dividends for VRA!.
Industry RankSector Rank
Dividend Yield 0%

VERA BRADLEY INC

NASDAQ:VRA (1/16/2026, 9:54:44 AM)

2.82

-0.02 (-0.7%)

Chartmill FA Rating
GICS IndustryGroupConsumer Durables & Apparel
GICS IndustryTextiles, Apparel & Luxury Goods
Earnings (Last)12-11
Earnings (Next)03-10
Inst Owners40.9%
Inst Owner Change0%
Ins Owners14.96%
Ins Owner Change11.87%
Market Cap78.79M
Revenue(TTM)284.73M
Net Income(TTM)-97.47M
Analysts45
Price Target5.61 (98.94%)
Short Float %10.84%
Short Ratio1.75
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-41.61%
Min EPS beat(2)-170.03%
Max EPS beat(2)86.8%
EPS beat(4)1
Avg EPS beat(4)-209.31%
Min EPS beat(4)-556.97%
Max EPS beat(4)86.8%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-5.37%
Min Revenue beat(2)-10.65%
Max Revenue beat(2)-0.08%
Revenue beat(4)0
Avg Revenue beat(4)-5.85%
Min Revenue beat(4)-10.65%
Max Revenue beat(4)-0.08%
Revenue beat(8)0
Avg Revenue beat(8)-8.3%
Revenue beat(12)1
Avg Revenue beat(12)-6.44%
Revenue beat(16)2
Avg Revenue beat(16)-5.81%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)0%
EPS NY rev (1m)-39.58%
EPS NY rev (3m)-39.58%
Revenue NQ rev (1m)3.17%
Revenue NQ rev (3m)3.17%
Revenue NY rev (1m)1.15%
Revenue NY rev (3m)1.15%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 55.84
P/S 0.28
P/FCF N/A
P/OCF N/A
P/B 0.62
P/tB 0.62
EV/EBITDA N/A
EPS(TTM)-0.98
EYN/A
EPS(NY)0.05
Fwd EY1.79%
FCF(TTM)-0.47
FCFYN/A
OCF(TTM)-0.2
OCFYN/A
SpS10.19
BVpS4.58
TBVpS4.58
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA -40%
ROE -76.11%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 45.45%
FCFM N/A
ROA(3y)-10.99%
ROA(5y)-5.57%
ROE(3y)-18.49%
ROE(5y)-9.46%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-1.8%
GM growth 5Y-1.67%
F-Score3
Asset Turnover1.17
Health
Industry RankSector Rank
Debt/Equity 0.08
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr -111.96%
Cap/Sales 2.59%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 2.52
Quick Ratio 0.81
Altman-Z 2.24
F-Score3
WACC11.36%
ROIC/WACCN/A
Cap/Depr(3y)68.99%
Cap/Depr(5y)55.33%
Cap/Sales(3y)1.74%
Cap/Sales(5y)1.49%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-308.33%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-11.11%
EPS Next Y-4.11%
EPS Next 2Y44.14%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-29.74%
Revenue growth 3Y-11.71%
Revenue growth 5Y-5.56%
Sales Q2Q%-22.74%
Revenue Next Year-30.39%
Revenue Next 2Y-15.9%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-279.35%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year-69.83%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-132.01%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-112.7%
OCF growth 3YN/A
OCF growth 5YN/A

VERA BRADLEY INC / VRA FAQ

Can you provide the ChartMill fundamental rating for VERA BRADLEY INC?

ChartMill assigns a fundamental rating of 2 / 10 to VRA.


What is the valuation status of VERA BRADLEY INC (VRA) stock?

ChartMill assigns a valuation rating of 1 / 10 to VERA BRADLEY INC (VRA). This can be considered as Overvalued.


How profitable is VERA BRADLEY INC (VRA) stock?

VERA BRADLEY INC (VRA) has a profitability rating of 1 / 10.


Can you provide the financial health for VRA stock?

The financial health rating of VERA BRADLEY INC (VRA) is 4 / 10.